To assess the distribution of splice variant neoantigens in different types of cancer, NeoSplice was run on TCGA LAML samples (n = 137) using healthy donor bone marrow-derived CD34+ hematopoietic stem cells as a reference normal. The gene discussed is CD34; the disease is cancer.